01 1Arzerra
02 5Kesimpta
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 372
2020 Revenue in Millions : 15
Growth (%) : 2,380
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 1,092
2021 Revenue in Millions : 372
Growth (%) : 194
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 2,171
2022 Revenue in Millions : 1,092
Growth (%) : 99
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 3,224
2023 Revenue in Millions : 2,171
Growth (%) : 49
Main Therapeutic Indication : Oncology
Currency : USD
2014 Revenue in Millions : -28.00%
2013 Revenue in Millions :
Growth (%) :
